Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $532.5500 (-2.15%) ($528.2800 - $547.0900) on Mon. Dec. 21, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.36% (three month average) | RSI | 47 | Latest Price | $532.5500(-2.15%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.3% a day on average for past five trading days. | Weekly Trend | REGN advances 0.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(64%) XLV(51%) XBI(49%) QQQ(42%) IVW(41%) | Factors Impacting REGN price | REGN will decline at least -1.18% in a week (0% probabilities). VIXM(-13%) TLT(-9%) UUP(-7%) SHY(-4%) TIP(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.18% (StdDev 2.36%) | Hourly BBV | 0 () | Intraday Trend | -2.5% | | | |
|
Resistance Level | $550.24 | 5 Day Moving Average | $548.88(-2.98%) | 10 Day Moving Average | $546.93(-2.63%) | 20 Day Moving Average | $550.24(-3.21%) | To recent high | -9.3% | To recent low | 17.9% | Market Cap | $56.466b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |